MicroStrategy Acquires $1.5 Billion Worth of Bitcoins Overview MicroStrategy, a technology company listed on the Nasdaq-100, recently made headlines with its massive acquisition of Bitcoins. The firm purchased 15,350 BTC for approximately $1.5 billion, at an average price of $100,386 per BTC. This acquisition adds to the 439,000 BTC that MicroStrategy already holds, which were…
The Magnificent Seven Stocks Surge, Leaving Cyclical Sectors Behind In the world of finance, the recent surge in the Magnificent Seven stocks has been the talk of the town. These stocks have outperformed the market and left cyclical sectors behind in their dust. Even bank stocks, which were once viewed as long-term bullish prospects due…
Bitcoin Reaches Record High Amid Trump’s Support and China’s Economic Concerns Bitcoin’s Surge Bitcoin has soared to a record high following President-elect Donald Trump’s public support for digital assets and his optimism regarding a proposal for a national Bitcoin stockpile. This newfound backing from a powerful political figure has instilled confidence in the cryptocurrency market,…
What’s Up with Bitcoin? The Latest on Bitcoin Price As of 9:50 a.m. UTC on Monday, December 16, Bitcoin is trading at $104,800, up 2.6% over the past twenty-four hours. Earlier today, Bitcoin reached an all-time high of $106,533 at 12:35 a.m. UTC, reflecting strong bullish momentum as the market awaits an important announcement from…
Caribou Biosciences (CRBU) Showing Signs of Potential Turnaround Technical Analysis Caribou Biosciences (CRBU) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. This is a bullish reversal pattern that suggests the stock may be poised for a rebound in the near future. Investors who follow…
Levi & Korsinsky Investigates Applied Therapeutics, Inc. for Securities Violations Hey there savvy investors and curious readers! Have you heard the latest scoop on Applied Therapeutics, Inc.? If not, let me fill you in on the juicy details. Levi & Korsinsky, one of the top-notch investigation firms in the financial world, has recently announced that…
Chimeric Antigen Receptor T-cell (CAR-T) Cell Therapy NXC-201 in Relapsed/Refractory AL Amyloidosis Patients Immix Biopharma Announces Compelling Clinical Activity of NXC-201 in AL Amyloidosis LOS ANGELES, Dec. 16, 2024 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and select immune-mediated…
Premium Catering (Holdings) Limited Receives Notice from Nasdaq December 16, 2024 SINGAPORE It seems like Premium Catering (Holdings) Limited is in a bit of a pickle! The company recently disclosed that it had received a notice from the Nasdaq Stock Market LLC regarding its non-compliance with the minimum market value of listing securities requirement. According…
